Skip to content Skip to sidebar Skip to footer
Woolworths vs Coles
Woolworths vs Coles: Which Supermarket Stock Wins This Reporting Season?
Woolworths vs Coles: Margin pressure meets reporting season Woolworths Group (ASX: WOW) and Coles Group (ASX: COL) are both reporting half-year results this week, and the timing could not be more telling. Woolworths goes first on Wednesday, February 25, followed by Coles on Friday, February 27, giving investors a rare Woolworths vs Coles side-by-side comparison…
Fisher & Paykel
Is Fisher & Paykel Healthcare (ASX:FPH) a Buy After Upgrading Guidance? The Tariff Risk Investors Are Ignoring
Fisher & Paykel Healthcare (ASX: FPH) lifted its FY26 guidance on Monday, now expecting around NZ$2.30 billion in revenue and NZ$450 million to NZ$470 million in net profit. Both figures sit comfortably above what management guided three months ago, and the shares rose around 4% to A$32.91. Strong hospital product sales and better margins are…
ASX reporting season
ASX Reporting Season Halftime Report: 4 Stocks to Buy, Hold, or Avoid After This Week’s Results
ASX Reporting Season: What This Week’s Results Mean for Investors We are halfway through the ASX reporting season, and the message from the market could not be clearer. Companies that deliver steady, reliable results are being rewarded. Companies priced for perfection are getting hammered at the first sign of weakness. The ASX 200 gained 1.8%…
Rio Tinto
Rio Tinto (ASX:RIO) Drops 3% Despite Record Copper Output: Is This a Buying Opportunity for Income Investors?
Rio Tinto’s FY2025 Result: What Income Investors Should Know Rio Tinto (ASX: RIO) dropped 3.1% to A$163.30 on Friday after its FY2025 results did not impress investors. Underlying earnings were flat at US$10.9 billion, while net profit fell 14% because expenses from the US$7.6 billion Arcadium Lithium acquisition reduced overall profit. However, we think the…
Alcidion
Alcidion (ASX:ALC) Wins Dual AI Healthcare Approval After Swinging to Profit- Time to Buy or Wait?
Alcidion Clears a Key AI Approval Hurdle Alcidion Group (ASX: ALC) hit a regulatory milestone that could open up its next phase of growth. The company has secured Class I Software as a Medical Device (SaMD) registration for the AI-powered concept detection feature inside its flagship Miya Precision platform, both in Australia and the United…
Chariot Resources
Chariot Resources (ASX:CC9) Surges 17% on CATL Supplier Deal: Speculative Buy or Too Early?
Chariot Resources Surges on CATL Supplier Deal Chariot Resources (ASX: CC9) surged 17% to A$0.17 after securing a binding A$1.425 million investment from Jiangsu Greatpower NexEnergy Technology, an affiliate of Shanghai Greatpower Nickel & Cobalt Materials. Greatpower supplies battery materials to some of the biggest names in the business, including CATL, LG Energy Solution, BMW,…
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here